Total Payments
$713.80
2024 Payments
$15.22
Companies
15
Transactions
74
Medicare Patients
1,549
Medicare Billing
$161,570
Payment Breakdown by Category
Food & Beverage$586.45 (82.2%)
Education$127.35 (17.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $586.45 | 41 | 82.2% |
| Education | $127.35 | 33 | 17.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $118.62 | 33 | $0 (2017) |
| Novo Nordisk Inc | $117.99 | 9 | $0 (2022) |
| Lilly USA, LLC | $98.90 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $60.61 | 4 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $50.73 | 4 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.70 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $46.60 | 2 | $0 (2017) |
| PFIZER INC. | $40.19 | 3 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $26.69 | 2 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $22.39 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.22 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($15.22) |
| 2023 | $17.71 | 1 | Lilly USA, LLC ($17.71) |
| 2022 | $121.88 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($33.48) |
| 2021 | $147.71 | 9 | Novo Nordisk Inc ($31.31) |
| 2020 | $103.21 | 7 | Lilly USA, LLC ($35.58) |
| 2019 | $23.99 | 2 | Novo Nordisk Inc ($23.99) |
| 2018 | $62.38 | 5 | AstraZeneca Pharmaceuticals LP ($39.71) |
| 2017 | $221.70 | 41 | Allergan Inc. ($118.62) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Education | In-kind items and services | $15.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 07/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes | ||||||
| 05/31/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/20/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardio-renal | ||||||
| 04/26/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $12.96 | General |
| Category: Cardiovascular | ||||||
| 04/21/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: Cardiovascular | ||||||
| 01/25/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Diabetes | ||||||
| 01/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/13/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: WOMENS HEALTH | ||||||
| 02/17/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/09/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 02/04/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Neuroscience | ||||||
| 01/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 11/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Diabetes | ||||||
| 11/02/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/17/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Diabetes | ||||||
| 07/08/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 296 | 408 | $59,208 | $31,946 |
| 2022 | 6 | 384 | 518 | $75,201 | $43,122 |
| 2021 | 7 | 421 | 560 | $75,056 | $46,099 |
| 2020 | 6 | 448 | 581 | $77,382 | $40,404 |
Total Patients
1,549
Total Services
2,067
Medicare Billing
$161,570
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 116 | 116 | $19,140 | $14,211 | 74.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 164 | $20,828 | $8,894 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 103 | $18,540 | $8,603 | 46.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 25 | $700.00 | $238.00 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 161 | 161 | $26,565 | $20,108 | 75.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 135 | $23,220 | $11,452 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 163 | $19,477 | $8,354 | 42.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 13 | 14 | $4,900 | $2,881 | 58.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 28 | $784.00 | $268.62 | 34.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 17 | $255.00 | $58.48 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 167 | 167 | $27,555 | $21,379 | 77.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 98 | 162 | $25,940 | $13,342 | 51.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 158 | $17,380 | $8,667 | 49.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 14 | 14 | $2,585 | $2,276 | 88.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 24 | 27 | $756.02 | $262.17 | 34.7% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $540.00 | $102.51 | 19.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 17 | 20 | $300.00 | $69.60 | 23.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 176 | 176 | $29,065 | $20,026 | 68.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 175 | $28,000 | $12,034 | 43.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 98 | 153 | $16,830 | $6,021 | 35.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 23 | 23 | $2,300 | $1,967 | 85.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 23 | 29 | $812.00 | $269.98 | 33.2% |
| 81002 | Urinalysis, manual test | Office | 2020 | 16 | 25 | $375.00 | $86.58 | 23.1% |
About Dr. Mark Skory, D.O
Dr. Mark Skory, D.O is a Family Medicine healthcare provider based in Auburn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417038449.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Skory, D.O has received a total of $713.80 in payments from pharmaceutical and medical device companies, with $15.22 received in 2024. These payments were reported across 74 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($586.45).
As a Medicare-enrolled provider, Skory has provided services to 1,549 Medicare beneficiaries, totaling 2,067 services with total Medicare billing of $161,570. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Auburn, MI
- Active Since 10/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417038449
Products in Payments
- VIBERZI (Drug) $77.52
- XARELTO (Drug) $60.61
- FARXIGA (Drug) $50.73
- ANORO (Drug) $46.60
- Ozempic (Drug) $41.10
- Tresiba (Drug) $34.60
- TRINTELLIX (Drug) $33.48
- EMGALITY (Drug) $31.47
- Livalo (Drug) $26.69
- CHANTIX (Drug) $26.58
- LINZESS (Drug) $25.99
- ENTRESTO (Drug) $22.39
- BASAGLAR (Drug) $19.53
- NEXLETOL (Drug) $19.28
- MOUNJARO (Drug) $17.71
- VRAYLAR (Drug) $17.67
- Rybelsus (Drug) $16.00
- UTIBRON (Drug) $15.82
- TRULICITY (Drug) $15.71
- GATTEX (Drug) $15.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Auburn
Dr. Mark Souder, Md, MD
Family Medicine — Payments: $26,799
Family Medicine $26,799
Dr. Richard Schlossberg, M.d, M.D
Family Medicine — Payments: $18,379
Family Medicine $18,379
Dr. Daniel Sewell, Md, MD
Family Medicine — Payments: $15,122
Family Medicine $15,122
Dr. James Gauthier, M.d, M.D
Family Medicine — Payments: $11,790
Family Medicine $11,790
Dr. Sarat Meka, Md, MD
Family Medicine — Payments: $10,718
Family Medicine $10,718
Adam Duckett, Do, DO
Family Medicine — Payments: $8,084
Family Medicine $8,084